Tonix Pharmaceuticals (TNXP) Short Interest Ratio & Short Volume

Short interest is the volume of Tonix Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 785,600 shares of TNXP short. 0.82% of Tonix Pharmaceuticals' shares are currently sold short. Learn More on Tonix Pharmaceuticals' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.82% of Tonix Pharmaceuticals' floating shares are currently sold short.

Tonix Pharmaceuticals saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 785,600 shares, a decrease of 50.9% from the previous total of 1,600,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Tonix Pharmaceuticals currently has issued a total of 95,540,000 shares. Some of Tonix Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tonix Pharmaceuticals currently has a public float of 95,540,000 shares.

0.82% of Tonix Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Tonix Pharmaceuticals: Orgenesis Inc. (0.72%), Aytu BioPharma, Inc. (7.82%), GlycoMimetics, Inc. (3.63%), Talphera, Inc. (0.72%), NeuroSense Therapeutics Ltd. (0.17%), Minerva Neurosciences, Inc. (0.50%), Galecto, Inc. (0.24%), KALA BIO, Inc. (0.25%), VBI Vaccines Inc. (1.18%), BioVie Inc. (1.79%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

Short selling TNXP is an investing strategy that aims to generate trading profit from Tonix Pharmaceuticals as its price is falling. TNXP shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Tonix Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TNXP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNXP, twice per month. The most recent reporting period available is May, 15 2024.